baber/WOPTO huggingface dataset:
Patent PT-1604407-E (PT)
Title: Tracking solar collector assembly
Inventor: SHINGLETON JEFFERSON G
IPC: F24S50/20
Filed: 2004-03-16
Abstract: A tracking solar collector assembly (200) includes Southside supports (212, 213, 214), North side supports (216, 217, 218) and support structures (236, 238). Each support structure has pivotal support points (224, 232) defining a tilt axis (237) and has at least one solar collector (240) mounted thereto. First support points (224) of first and second support structures are pivotally connected to first and second Southside supports (212, 213). A second support point (232) of the first support structure is pivotally connected to first and second North side supports (216, 217). A second support point of the second support structure is pivotally C5 connected to second and third North side supports (217, 218). The assembly further includes a tilting assembly (206) causing the solar collector support structures and the solar collectors therewith to tilt in unison. Another aspect of the invention is directed to tracking solar collector of the type comprising a torsion tube (32) mounted for rotation about a torsion tube axis (A); the improvement comprises mounting structure (152, 154) securing the solar panels (34A) to the torsion tube at a chosen angle (B) to the torsion tube axis with each of the solar panels located entirely vertically above the torsion tube axis when the torsion tube is at the noontime angular orientation.
Patent PT-1680418-E (PT)
Title: Derivatives of n-[heteroaryl(piperidine-2-yl)methyl]benzamide, preparation method thereof and application of same in therapeutics
Inventor: DARGAZANLI GIHAD
IPC: A61P25/00
Filed: 2004-10-15
Abstract: N-Piperidinylmethyl benzamide derivatives (I) are new. N-Piperidinylmethyl benzamide derivatives of formula (I) and their acid addition salts, hydrates and solvates are new. [Image] R 1H, 1-7C alkyl (optionally fluorinated), 3-7C cycloalkyl, (3-7C)cycloalkyl(1-3C)alkyl, phenyl(1-3C)alkyl (optionally mono- or disubstituted with OMe), 2-4C alkenyl or 2-4C alkynyl; R 2pyridyl, furyl, thienyl, thiazolyl or oxazolyl, all optionally substituted with halo, CF 3, 1-6C alkyl and 1-6C alkoxy; R 3H, halo, CF 3, 1-6C alkyl, 3-7C cycloalkyl, 1-6C alkoxy, phenyl, CN, acetyl, benzoyl, 1-6C alkylthio, 1-6C alkylsulfonyl, COOH, 1-6C alkoxycarbonyl, NR 4R 5, SO 2NR 4R 5 or CONR 4R 5; R 4, R 5H, 1-6C alkyl or 3-7C cycloalkyl, or NR 4R 5 is pyrrolidino, piperidino or morpholino. ACTIVITY : Nootropic; Neuroleptic; Tranquilizer; Antidepressant; Antialcoholic; Antimigraine; Relaxant; Analgesic; Antiparkinsonian; Anticonvulsant; Neuroprotective. MECHANISM OF ACTION : Glycine transporter inhibitor. The most active compounds (unspecified) have IC50 values of 0.001-1 MicroM against glycine uptake by SK-N-MC cells expressing native human glycine transporter glyt1.
Patent PT-1723188-E (PT)
Title: Swell-resistant polyurethane integral foams
Inventor: BIEDERMANN ANJA
IPC: C08G18/48
Filed: 2005-02-19
Abstract: The invention relates to swelling-resistant integral polyurethane foams obtainable by reacting polyisocyanate prepolymers (a) with a polyol mixture (b) comprising a polyether polyol (b1) based on a bifunctional starter molecule and a polyether polyol (b2) based on a trifunctional to pentafunctional starter molecule, with the polyols (b1) and (b2) being prepared by alkoxylation by means of ethylene oxide (hereinafter referred to as EO) and propylene oxide (hereinafter referred to as PO), having an ethylene oxide content of more than 50% by weight and at least 5% of the ethylene oxide being present as an EO end cap.
Patent PT-1786790-E (PT)
Title: Oxazole derivatives as histamine h3 receptor agents, preparation and therapeutic uses
Inventor: HORNBACK WILLIAM J
IPC: A61K31/422
Filed: 2005-07-14
Abstract: The present invention discloses novel aryl oxazole compounds of Formula I (I), or pharmaceutically acceptable salts thereof, which have histamine-H3 receptor antagonist or inverse agonist activity, as well as methods for preparing and using such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising compounds of Formula I as well as methods of using these compositions to treat obesity, cognitive deficiencies, narcolepsy, and other histamine H3 receptor-related diseases. Formula I (I) or a pharmaceutically acceptable salt thereof, wherein: m is independenlly at each occurrence 1, 2, or 3, Z independently represents carbon (substituted with hydrogen or the optional substituents indicated herein) or nitrogen, provided that when Z is nitrogen then R6 is not attached to Z; R1 and R2 are independently —(C1—C7) alkyl (optionally substituted with one to three halogens), or R1 and R2 and the nitrogen to which they are attached form an azetidinyl ring, a pyrrolidinyl ring, or a piperidinyl ring, wherein further the azetidinyl, pyrrolidinyl, or piperidinyl ring so formed may be optionally substituted one to three times with R5; R6 is independently at each occurrence —H, -halogen, or —CH3.
Patent PT-1686119-E (PT)
Title: Pyrimidine-5-one derivatives as ldl-pla2 inhibitors
Inventor: STANWAY STEVEN JAMES
IPC: C07D239/70
Filed: 2001-02-13
Abstract: Pyrimidinone compounds of formula (I) are inhibitors of the enzyme LpPLA2 and are useful in the treatment of atherosclerosis
Patent PT-1866223-E (PT)
Title: Device and method for orienting preforms used to produce plastics containers by blow moulding
Inventor: KLAIBER FRANZ
IPC: B29C49/42
Filed: 2006-02-06
Abstract: The device has a turntable (20) that turns about an axis of rotation (R) and holds irregularly arranged preforms. Above (20) and in the circumference region a guide element (12) is positioned so that a gap (13) is formed between (20) and (12) for picking up the preforms by their collars (4) and moving them along (12) in the direction of rotation. An adjoining main body portion (6) of the preform is passed radially outwards through (13). (12) Is arranged in a circle or spiral in the plan view. An independent claim is included for a method for arranging in a same attitude elongated, preferably cylindrical articles having a profiled contour.
Patent PT-1893899-E (PT)
Title: Device for interrupting delay of a delayed closing valve
Inventor: DUTHEIL DANIEL
IPC: F16K21/04
Filed: 2006-05-17
Abstract: The invention concerns a device for interrupting delay of a delayed closing valve of the type comprising a delaying chamber (8) including a mobile piston (7) whereof the movement is capable of closing or releasing the seat (5) interposed between the water inlet and exit characterized in that a pipe (18-20), whereon is interposed a closure means, connects the water inlet (3) to the delaying chamber (8).
Patent PT-1937328-E (PT)
Title: Polymer coating for medical devices
Inventor: RYPACEK FRANTISEK
IPC: A61L33/00
Filed: 2006-10-12
Abstract: Coatings are provided in which surfaces may be activated by covalently bonding a silane derivative to the metal surface, covalently bonding a lactone polymer to the silane derivative by in situ ring opening polymerization, and depositing at least one layer of poly(lactide-co-caprolactone) copolymer on the bonded lactone. Biologically active agents may be disposed with the poly(lactide-co-caprolactone) copolymer layers. Such coated surfaces may be useful in medical devices, in particular stents.
Patent PT-2152561-E (PT)
Title: Device and method for error monitoring for undercarriage components of rail vehicles
Inventor: FRIESEN ULF
IPC: B61K9/00
Filed: 2008-05-16
Abstract: The invention relates to a device for monitoring errors in undercarriage components of rail vehicles, having at least one acceleration sensor which works with an evaluation unit. At least one acceleration sensor is arranged on the undercarriage of the rail vehicle in such a manner that its direction of detection has at least one component parallel to the vertical axis (z-direction) of the rail vehicle. The invention proposes that the acceleration sensor is constructed in such a manner that it delivers a measuring signal which contains the signal portion corresponding to a ground acceleration, or represents a signal corresponding to a ground acceleration, and that the evaluation unit has a routine for testing functions of the acceleration sensor, the routine controlling an error signal if the measuring signal delivered by the acceleration sensor contains no signal portion corresponding to a ground acceleration. The routine also suppresses the error signal if this is not the case.
Patent PT-2100520-E (PT)
Title: Improvement of intestinal barrier integrity
Inventor: STAHL BERND
IPC: A23L33/00
Filed: 2004-06-22
Abstract: The invention concerns a method for stimulating barrier integrity in a mammal by administering to a mammal a composition comprising: eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA) and arachidonic acid (ARA),; and at least two distinct oligosaccharides.
Patent PT-2292962-E (PT)
Title: Press fitting for a pipe
Inventor: DITTMAR RAINER
IPC: F16L13/14
Filed: 2007-07-26
Abstract: The fitting (10) has a press shell (16) plastically deformable for pressing against a support shell (14). An abutment element (30) is arranged on a press shell and includes an abutment face (34) to be abutted by a pressing tool (26) for plastically deforming the press shell. A press indication portion (40) projects from the abutment face of the abutment element. The press indication portion includes a guidance recess (44) for accommodating a guidance projection (48) of the tool for axial fixation of the press shell relative to the tool during the deformation of the press shell.
Patent PT-606869-E (PT)
Inventor: WALLACH DAVID
IPC: C12N15/85
Filed: 1994-01-10
Abstract: A promoter sequence of the human p55 TNF-R gene is provided. Also provided are sequence motifs and motif regions contained within the promoter sequence. Methods for preparing these motifs or motif regions and their use in the modulation of TNF function are also provided.
Patent PT-808164-E (PT)
Inventor: MEIER ALBERT H
IPC: A61K31/445
Filed: 1995-01-06
Abstract: The present invention is directed to an improvement in a method of weight and/or body-fat reduction comprising a (preferably moderate) reduction in the caloric intake of a subject in need of such treatment in combination with administration to said subject of a prolactin inhibitor. Additionally, the present invention is directed to an improvement in a method for altering and/or resetting prolactin profiles (and thereby controlling one or more metabolic disorders such as obesity, excessive body fat, hyperlipidemia, hyperlipoproteinemia, hyperglycemia, hypercholesterolemia, hyperinsulinemia, insulin resistance, glucose intolerance, and Type II diabetes) comprising administration to a subject in need of such treatment of a prolactin inhibitor at a predetermined time or times during a 24-hour period in combination with a (preferably moderate) reduction of the caloric intake of said subject.
Patent PT-806952-E (PT)
Inventor: CHWALISZ KRISTOF
IPC: A61K31/57
Filed: 1995-02-02
Abstract: Competitive progesterone antagonists (antigestagens) are suitable for the production of pharmaceutical agents for the treatment of forms of dysfunctional uterine bleeding (metrorrhagias, menorrhagias, hypermenorrhea).
Patent PT-792358-E (PT)
Inventor: CONTENT JEAN
IPC: A61K48/00
Filed: 1995-11-13
Abstract: Genes encoding Mycobacterium tuberculosis (M.tb) proteins were cloned into eukaryotic expression vectors to express the encoded proteins in mammalian muscle cells in vivo. Animals were immunized by injection of these DNA constructs, termed polynucleotide vaccines or PNV, into their muscles. Immune antisera was produced against M.tb antigens. Specific T-cell responses were detected in spleen cells of vaccinated mice and the profile of cytokine secretion in response to antigen 85 was indicative of a Th1 type of helper T-cell response (i.e., high IL-2 and IFN-gamma). Protective efficacy of an M.tb DNA vaccine was demonstrated in mice after challenge with M.bovis BCG, as measured by a reduction in mycobacterial multiplication in the spleens and lungs of M.tb DNA-vaccinated mice compared to control DNA-vaccinated mice or primary infection in naive mice.
Patent PT-863876-E (PT)
Inventor: KIRSTEIN DORTE
IPC: A61K31/47
Filed: 1996-11-13
Abstract: PCT No. PCT/DK96/00467 Sec. 371 Date Jan. 13, 1998 Sec. 102(e) Date Jan. 13, 1998 PCT Filed Nov. 13, 1996 PCT Pub. No. WO97/19925 PCT Pub. Date Jun. 5, 1997The present invention relates to hitherto unknown compounds of formula (I) in which R1 is hydrogen or halogen, preferably fluorine or chlorine, and m is 0, 1 or 2. The present compounds are of value in the human and veterinary practice as leukotriene antagonists.
Patent PT-980456-E (PT)
Inventor: SVENSSON PEEHR MATHIAS ORNFELD
IPC: E04D1/28
Filed: 1998-04-30
Abstract: A pre-manufactured roof plate element comprising a number of longitudinal box-shaped girders of steel plate, which are upwardly connected with a compressive force plate with almost the same width as the girder, and which preferably are positioned in each side and in the middle of the element. The compressive force plate consists of a corrugated steel plate having a preferably trapezoid shape. A box-shaped girder of the said type is a complement to the roof plate element. A roof plate element or a girder according to the invention may be produced totally without use of organic material.
Patent PT-1032660-E (PT)
Title: Method of identifying binding site domains that retain the capacity of binding to an epitop
Inventor: RAUM TOBIAS
IPC: G01N33/577
Filed: 1998-11-16
Abstract: The present invention relates to a method of identifying binding site domains that retain the capacity of binding to an epitope when positioned C-terminal of at least one further domain in a recombinant bi- or multivalent polypeptide. The present invention further relates to a kit comprising components such as panels of recombinant vectors of bacterial libraries transfected with a panel of recombinant vectors which is useful in carrying out the method of the invention. Furthermore, binding site domains and fusion proteins obtainable by the method of the invention as well as antibody-like molecules comprising such domains and proteins are described. Furthermore, pharmaceutical and diagnostic compositions containing the above-described fusion proteins and polypeptides are provided.
Patent PT-1121103-E (PT)
Title: Orally disintegrable tablets comprising a benzimidazole
Inventor: SHIMIZU TOSHIHIRO
IPC: A61K9/26
Filed: 1999-05-17
Abstract: An orally disintegrable tablet, of the present invention, which comprises (i) fine granules having an average particle diameter of 400 mu m or less, which fine granules comprise a composition coated by an enteric coating layer, said composition having 10 weight % or more of an acid-labile physiologically active substance and (ii) an additive, has superior disintegrability or dissolution in the oral cavity so that it can be used for treatment or prevention of various diseases, as an orally disintegrable tablet capable of being administered to the aged or children and easily administered without water. Also, because the tablet of the present invention contains fine granules having the average particle diameter such that it will not impart roughness in mouth, it can be administered easily without discomfort at the administration.
Patent PT-1079806-E (PT)
Inventor: FLEISCHER WOLFGANG
IPC: A61K9/50
Filed: 1999-05-27
Abstract: Use of an anti-inflammatory agent such as povidone iodine for the preparation of a pharmaceutical composition for the treatment of diseases of the lower respiratory tract which are susceptible to the administration of such agents.
Patent PT-1105701-E (PT)
Inventor: BOHM ALFRED
IPC: G01F23/00
Filed: 1999-07-15
Abstract: The system includes a filling level measuring unit (18,18,20,22) essentially inside the tank (6) for determining the position of at least one boundary surface (24) of the medium (4) in the tank (6). The measuring unit has at least one dipstick (16). A trassonar displacement pick-up with at least one dipstick (16) and at least one float (20) is provided working according to the magnetostrictive principle, as the filling level measuring unit (16,18,20,22), which is coupled with a computer system (48).
Patent PT-1124733-E (PT)
Inventor: FRUTIN BERNARD DEREK
IPC: B65D81/32
Filed: 1999-10-28
Abstract: The invention relates to an apparatus for introducing an additive component (131) in the form of a liquid or granulated solid into a liquid (40) stored in a first container (150). The additive component (131) is stored separately from the liquid (40) in a dip tube or conduit (132). The container (150) has an opening closed by a releasable closure (152). A second container or tank (111) containing pressurized propellant fluid (116) is positioned in the neck or closure of the first container, adjacent to the opening. The dip tube or conduit (132) has a first end communicating with the tank and a second end extending down into the first liquid in the first container. The dip tube (132) contains an additive (131) which is expelled from the dip tube into the first liquid by the entry of the propellant fluid from the tank into the dip tube on release of the releasable closure. A valve (300) may be provided at the free end of the dip tube (132) to prevent mixing of the liquid and additive during transport and/or storage. The dose of additive may be accurately measured, and the action of the propellant ensures that all the additive is expelled into the liquid. The additive may be provided in liquid or pourable solid form.
Patent SG-66087-G (SG)
Title: Projectile for firearms
IPC: F42B/
Filed: 1987-08-13
Abstract: PCT No. PCT/FR83/00228 Sec. 371 Date Jul. 18, 1984 Sec. 102(e) Date Jul. 18, 1984 PCT Filed Nov. 24, 1983 PCT Pub. No. WO84/02183 PCT Pub. Date Jun. 7, 1984.The projectile comprises a central core, a rear body of which the diameter determines the gauge of the projectile, and an interlock for the central core with the rear body. This interlock comprises a conical sleeve coupling formed by a conical recess and a conical finger, having complementary shapes arranged to provide a self-clamping effect. The rear body comprises at least one bulge cooperating with the gun barrel of the armament and at least one hollow. The bulge and hollow being interconnected progressively so as to define a continuous sinuous shape.
Patent IE-860018-L (IE)
Title: Quinolonecarboxylic acids formulations
IPC: A61P31/04
Filed: 1986-01-03
Abstract: Improvement in the parenteral administration of a carboxylic acid of the formula    <IMAGE>  (I)  or   <IMAGE> (II)  in which X is N, C-H or C-F, Z is O or Ch2, R1 is hydrogen, methyl, ethyl or  beta -hydroxyethyl, R2 is cyclopropyl, 2-fluoroethyl or ethyl, R3 is hydrogen or methyl, and R4 is H or methyl, is achieved through the administration of the basic salt of the acid (I, II). Surprisingly the basic salts are suitable and stable.
Patent IE-32846-L (IE)
Title: Fastening rails to sleepers
IPC: E01B9/00
Filed: 1969-03-10
Abstract: 1,255,412. Securing railway rails to sleepers. SOC D'ETUDES FERROVIAIRES. 28 Feb., 1969 [15 March, 1968], No. 10848/69. Heading E1G. In an insulated resilient rail fastening a rail flange 2 is clamped to a sleeper 1 by a bolt 5 passing through a spring steel strip 17 bearing on a rectangular plastics body 10 provided with opposed arms 12, 13 seating respectively on the flange 2 and sleeper 1. The concrete sleeper shown has an angular lateral abutment face 8. For a metal sleeper, Fig. 2 (not shown), the lateral abutment face (28) is provided on a separate member (22). For a concrete sleeper, Fig. 3 (not shown) having a conventional curved abutment face (38) the body (10) is modified to provide a rounded seating boss (33).
[GB1255412A]
Patent IE-840343-L (IE)
Title: 2-nitromethylene tetrahydro 1,3-thiazines
IPC: C07D417/06
Filed: 1984-02-15
Abstract: A 3-acyl-2-nitromethylene-tetrahydro-2H-1,3-thiazines of the general formula: <IMAGE> (I) in which R represents an optionally ring-substituted benzyl group; a cycloalkyl group optionally substituted by halogen and/or alkyl; or an alkyl, alkenyl or alkynyl group of 2 or more carbon atoms optionally substituted by one or more of the same or different substituents selected from halogen, optionally substituted phenyl, phthalimido, alkoxy, haloalkoxy, alkoxyalkoxy, hydroxy, thiol, cycloalkyl optionally substituted by halogen and/or alkyl, and groups of the formula -COR1, -X.CO.R1 or -CO.X.
[US4529726A]
Patent IE-37379-L (IE)
Title: Forming twisted bars
IPC: A21D13/00
Filed: 1973-03-07
Abstract: 1410415 Twisting pastry strips LU BRUN & ASSOCIES SA 12 March 1973 [10 March 1972] 11827/73 Heading B5A Articles in the shape of twsited bars are formed from a strip of pastry or the like by (a) cutting the strip transversely into ribbons, (b) gripping each ribbon transversely at points spaced along its length, the extreme gripped portions being the terminal parts of the ribbon, (c) twisting the ribbon about its longitudinal axis to form a twisted part between adjacent gripped portions and (d) flattening each twisted part. As shown, a sheet or strip B of pastry is supplied on belt C11, cut into ribbons r and fed between upper and lower arrays of belts comprising gripping belts (C3), C4, a lower input belt C9 upper and lower twisting belts (C1), C2, output belts (C5), C6 and twisting flattening belts (C7), C8 and thence to discharge belt C12 where the twisted ribbon is cut by discs D while being held by belts C10. Twists are formed at v by 180 degree rotational movements of the twisting device including belts (C1), C2 moved in steps between the steps of movement of belt C11 and the cutter.
[GB1410415A]
Patent IE-34217-L (IE)
Title: Laminated web
IPC: B32B27/00
Filed: 1970-05-21
Abstract: A woven web of tapes made from a blend of from 50 to 90 percent of a crystalline polyolefine and from 10 to 50 percent of another polyolefine coated with a polyolefine based coating composition.
[US3660152A]
Patent FI-822317-L (FI)
Inventor: CHEKROUN ISAAC
IPC: C07D333/20
Filed: 1982-06-29
Abstract: Prepn. of 2-(2- and 3-thienyl)ethylamines of formula (I) is claimed (where R1 is in posn. 2, 3, 4 or 5 and is H, alkyl, aromatic gp. which may be a heterocycle (and is opt. mono- or poly-substd. by alkyl, phenyl, halogen, nitro, cyano, amino, carboxy or alkoxy), alkoxy, halogen, nitro, carboxy, cyano or amino; the aminoethyl chain may occupy posn. 2 or 3; R2 is H, alkyl or atomatic gp. which may be a heterocycle (and may be substd. as above); Ar is aromatic gp. which may be a heterocycle (and may be substd. as above)). Process comprises (a) heating (V) to give (VI); (b) treating with water to give (VII); (c) reducing to give (VIII); (d) reacting this with a base, followed by a halogen deriv. Ar-CH(Hal)-R2 to give (X) and (e) treatment of (X) with acid to give (I) (where X and Y are alkyl, aryl, alkoxy, aryloxy, dialkyl- or diarylamino; M is a cation, pref. alkali or alkaline earth metal). (I) are intermediates for chemical prods. and pharmaceuticals.